The risk of new onset heart failure associated with dopamine agonist use in Parkinson's disease.

@article{Mokhles2012TheRO,
  title={The risk of new onset heart failure associated with dopamine agonist use in Parkinson's disease.},
  author={Mostafa M. Mokhles and Gianluca Trifir{\`o} and Jeanne P. Dieleman and Mendel Haag and Eva Marianne van Soest and Katia Verhamme and Giampiero Mazzaglia and Ron Herings and Cynthia de Luise and Douglas J. Monterey Ross and Guy G Brusselle and Annamaria Colao and Willem Haverkamp and Ren{\'e} Schade and Guy Van Camp and Renzo Zanettini and Miriam C. J. M. Sturkenboom},
  journal={Pharmacological research},
  year={2012},
  volume={65 3},
  pages={358-64}
}
The aim of present study was to investigate the risk of heart failure associated with dopamine agonist use in patients with Parkinson's disease. The data sources of this study were four different population-based, healthcare databases in United Kingdom, Italy and Netherlands. A case control study nested within a cohort of Parkinson's disease patients who were new users of either dopamine agonist or levodopa was conducted. Incident cases of heart failure were identified and validated, using… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 1 time over the past 90 days. VIEW TWEETS

From This Paper

Topics from this paper.

Citations

Publications citing this paper.
Showing 1-10 of 18 extracted citations

Similar Papers

Loading similar papers…